⏳ Fetching live dividend data...
Home › Calculator › MNKPF Dividend Calculator 2026
Mallinckrodt plc · OTC
Price: $17.25 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in MNKPF → $9.00M in 10 years · $108.86/month
Mallinckrodt plc (MNKPF) is a global pharmaceutical company focused on the development, production, and commercialization of specialized medicinal products and treatments. Its operations span the United States, Europe, the Middle East, Africa, and other international markets. The company's business is structured into two main divisions: Specialty Brands and Specialty Generics. Within its Specialty Brands segment, Mallinckrodt offers a range of proprietary pharmaceutical solutions. These target autoimmune and rare conditions across various therapeutic areas, including neurology, rheumatology, nephrology, ophthalmology, pulmonology, and oncology. The segment also encompasses immunotherapy, critical care therapies for neonates, pain management medications (analgesics), advanced cultured skin substitutes, and gastrointestinal treatments. Key products include Acthar Gel, a corticotropin injection prescribed for a spectrum of conditions such as rheumatoid arthritis, infantile spasms, lupus, multiple sclerosis, and severe inflammatory diseases. INOmax serves as a vasodilator to improve oxygenation, potentially reducing the necessity for extracorporeal membrane oxygenation. Other notable offerings include Therakos photopheresis, an immunotherapy platform; Amitiza, used for constipation relief; and StrataGraft, a treatment designed for deep partial-thickness burns in adults. Furthermore, Mallinckrodt maintains an active development pipeline, featuring Terlipressin for hepatorenal syndrome and SLN 501, a promising ribonucleic acid silencing therapy. The Specialty Generics segment focuses on providing essential generic medications and active pharmaceutical ingredients (APIs). Its branded products are distributed to a wide array of healthcare professionals and institutions, including physicians, respiratory therapists, pharmacists, and various purchasing entities such as hospital procurement departments, ambulatory surgical centers, and specialty pharmacies. Mallinckrodt plc also engages in strategic collaborations, notably with Silence Therapeutics plc, to advance the development and commercialization of ribonucleic acid interference (RNAi) drug targets. Established in 1867, the company maintains its headquarters in Dublin, Ireland.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open MNKPF position with:
Real after-tax yield depends on where you live and how you hold MNKPF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 11.59% | 8.79% | $1,159 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 9.85% | 7.05% | $985 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 9.27% | 6.47% | $927 / yr |
| 🇬🇧 UK ISA | 0% | 11.59% | 8.79% | $1,159 / yr |
| 🇬🇧 UK Taxable | 8.75% | 10.58% | 7.78% | $1,058 / yr |
| 🇨🇦 TFSA | 0% | 11.59% | 8.79% | $1,159 / yr |
| 🇨🇦 CA Taxable | 25% | 8.69% | 5.89% | $869 / yr |
| 🇦🇺 Super (pension) | 15% | 9.85% | 7.05% | $985 / yr |
| 🇦🇺 AU Taxable | 30% | 8.11% | 5.31% | $811 / yr |
| 🇩🇪 DE Taxable | 26.375% | 8.53% | 5.73% | $853 / yr |
| 🇫🇷 FR Taxable | 30% | 8.11% | 5.31% | $811 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
MNKPF pays quarterly — 4 times per year. Next ex-div: TBD.
How MNKPF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for MNKPF sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Buy | 2023-12-05 | 75,000 | $37.50 | $2.81M | ||
| J-Other | 2023-11-14 | 1,093,857 | — | — | ||
| J-Other | 2023-11-14 | 2,033,257 | — | — | ||
| D-Return | 2023-11-14 | 32,000 | — | — | ||
| D-Return | 2023-11-14 | 672,948 | — | — | ||
| D-Return | 2023-11-14 | 189,863 | — | — | ||
| D-Return | 2023-11-14 | 62,288 | — | — | ||
| D-Return | 2023-11-14 | 96,660 | — | — | ||
| D-Return | 2023-11-14 | 33,133 | — | — | ||
| D-Return | 2023-11-14 | 75,091 | — | — |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Revenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the MNKPF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Mallinckrodt plc (MNKPF) is currently trading at $17.25, 29% below its 52-week high. The current dividend yield is 11.59% based on an annual payout of $2.00 per share.
Mallinckrodt plc (MNKPF) is a healthcare stock currently trading at $17.25 with a dividend yield of 11.59%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
⏱️ Takes 30 seconds · No signup · Free forever